Pacific Diabetes Technologies, Inc. — Form D
Pacific Diabetes Technologies, Inc. of PORTLAND, OR, a company, filed a Form D exempt-offering notice with the SEC on 2023-09-13. The offering totals $5.0M, of which $500K was reported sold. Industry: Biotechnology.
Offering
- Filed: 2023-09-13
- Form: D
- Accession: 0001835476-23-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $5.0M
- Amount sold: $500K
- Remaining: $4.5M
- Minimum investment: $250K
- Investors: 1
- Date of first sale: 2023-09-05
- Revenue range: Decline to Disclose
- SEC file number: 021-491997
Issuer
- Name: Pacific Diabetes Technologies, Inc.
- CIK: 0001835476
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 12172 SW GARDEN PL, PORTLAND, OR, 97223
- Phone: 503-847-9170
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Thomas Seidl | Director | Portland, OR |
| Thomas Seidl | Executive Officer | Portland, OR |
| Thomas Seidl | Promoter | Portland, OR |
| Hank Wuh | Director | Portland, OR |
| Christopher Marsh | Director | West Linn, OR |
| Mark Huber | Director | Portland, OR |
| Peter Eckenberg | Director | Portland, OR |
| Kenneth Ward | Director | Portland, OR |
| Ed La Cava | Director | Portland, OR |
| Ken Ward | Director | Las Vegas, NV |
| Edward La Cava | Director | Portland, OR |
| Thomas Seidel | Director | Portland, OR |
| Thomas Seidel | Executive Officer | Portland, OR |
| Yobie Benjamin | Director | Portland, OR |
Other filings by this issuer (5)
More